ASIA-PACIFIC MEDICAL ENZYMES MARKET 2022-2028

 

 

TABLE OF CONTENTS   

1.     ASIA-PACIFIC MEDICAL ENZYMES MARKET - SUMMARY

2.     INDUSTRY OUTLOOK

2.1.                   IMPACT OF COVID-19 ON THE MEDICAL ENZYMES MARKET

2.2.                   KEY INSIGHTS

2.2.1.    ADVANCEMENTS IN ENZYME ENGINEERING

2.2.2.    INCREASED DEMAND IN THE PHARMACEUTICAL SECTOR

2.3.                   PORTER’S FIVE FORCES ANALYSIS

2.3.1.    THREAT OF NEW ENTRANTS

2.3.2.    THREAT OF SUBSTITUTES

2.3.3.    BARGAINING POWER OF BUYERS

2.3.4.    BARGAINING POWER OF SUPPLIERS

2.3.5.    THREAT OF COMPETITIVE RIVALRY

2.4.                   KEY IMPACT ANALYSIS

2.4.1.    PRICE

2.4.2.    QUALITY

2.4.3.    USAGE

2.5.                   MARKET ATTRACTIVENESS INDEX

2.6.                   VENDOR SCORECARD

2.7.                   INDUSTRY COMPONENTS

2.7.1.    RESEARCH AND DEVELOPMENT

2.7.2.    OPERATIONS

2.7.3.    OUTBOUND LOGISTICS

2.8.                   REGULATORY FRAMEWORK

2.9.                   KEY MARKET STRATEGIES

2.9.1.    MERGERS & ACQUISITIONS

2.9.2.    PRODUCT LAUNCHES & DEVELOPMENTS

2.9.3.    PARTNERSHIPS & AGREEMENTS

2.9.4.    BUSINESS EXPANSIONS & DIVESTITURES

2.10.               MARKET DRIVERS

2.10.1.                    RISING INVESTMENTS IN RESEARCH AND DEVELOPMENT

2.10.2.                    RISING AGING POPULATION AND OCCURRENCE OF CHRONIC DISEASES

2.10.3.                    INCREASING APPLICATIONS IN THE PHARMACEUTICAL INDUSTRY

2.11.               MARKET CHALLENGES

2.11.1.                    STRICT REGULATIONS

2.11.2.                    SAFETY CONCERNS WHILE HANDLING ENZYMES

2.12.               MARKET OPPORTUNITIES

2.12.1.                    RISING HEALTH ISSUES AND GROWING AWARENESS

2.12.2.                    RISING DEMAND FOR SPECIALTY ENZYMES

3.     ASIA-PACIFIC MEDICAL ENZYMES MARKET OUTLOOK - BY PRODUCT TYPE

3.1.                   HYDROLASE

3.1.1.    HYALURONIDASE

3.1.2.    LYSOZYMES

3.1.3.    OTHER HYDROLASES ENZYMES

3.2.                   THROMBOLYTIC ENZYME

3.2.1.    STREPTOKINASE

3.2.2.    UROKINASE

3.2.3.    OTHER THROMBOLYTIC ENZYMES

3.3.                   DIGESTIVE ENZYME

3.3.1.    LACTASE

3.3.2.    L-ASPARAGINASE

3.3.3.    OTHER DIGESTIVE ENZYMES

3.4.                   ENDONUCLEASE

3.4.1.    BENZONASE

3.4.2.    OTHER ENDONUCLEASES

4.     ASIA-PACIFIC MEDICAL ENZYMES MARKET OUTLOOK - BY APPLICATION

4.1.                   DISEASE TREATMENT

4.2.                   DIAGNOSTIC TOOLS

4.3.                   BIOMEDICAL RESEARCH

4.4.                   OTHER APPLICATIONS

5.     ASIA-PACIFIC MEDICAL ENZYMES MARKET – COUNTRY OUTLOOK

5.1.                   CHINA

5.2.                   JAPAN

5.3.                   INDIA

5.4.                   SOUTH KOREA

5.5.                   ASEAN COUNTRIES

5.6.                   AUSTRALIA & NEW ZEALAND

5.7.                   REST OF ASIA-PACIFIC

6.     COMPETITIVE LANDSCAPE

6.1.                   BASF SE

6.2.                   DUPONT

6.3.                   ROCHE HOLDING AG

6.4.                   NOVOZYMES

6.5.                   DSM

6.6.                   SANOFI SA

6.7.                   CODEXIS

6.8.                   ADVANCED ENZYMES

6.9.                   AMANO ENZYME

6.10.               BBI SOLUTIONS

6.11.               THERMOFISHER SCIENTIFIC INC

6.12.               CPC BIOTECH

6.13.               NOVUS

6.14.               BRAIN BIOTECH AG

6.15.               SEKISUI

7.     RESEARCH METHODOLOGY & SCOPE

7.1.                   RESEARCH SCOPE & DELIVERABLES

7.2.                   SOURCES OF DATA

7.3.                   RESEARCH METHODOLOGY

 

 

 LIST OF TABLES

TABLE 1: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY COUNTRY, 2022-2028 (IN $ MILLION)

TABLE 2: APPLICATIONS OF ENZYMES IN THE PHARMACEUTICALS INDUSTRY

TABLE 3: VENDOR SCORECARD

TABLE 4: REGULATORY FRAMEWORK

TABLE 5: LIST OF MERGERS & ACQUISITIONS

TABLE 6: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 7: LIST OF PARTNERSHIPS & AGREEMENTS

TABLE 8: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

TABLE 9: MEDICAL APPLICATION OF VARIOUS ENZYMES

TABLE 10: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY PRODUCT TYPE, 2022-2028 (IN $ MILLION)

TABLE 11: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY HYDROLASE ENZYME, 2022-2028 (IN $ MILLION)

TABLE 12: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYME, 2022-2028 (IN $ MILLION)

TABLE 13: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, 2022-2028 (IN $ MILLION)

TABLE 14: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY ENDONUCLEASE, 2022-2028 (IN $ MILLION)

TABLE 15: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY APPLICATION, 2022-2028 (IN $ MILLION)

TABLE 16: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY COUNTRY, 2022-2028 (IN $ MILLION)

 

LIST OF FIGURES

FIGURE 1: KEY BUYING IMPACT ANALYSIS

FIGURE 2: MARKET ATTRACTIVENESS INDEX

FIGURE 3: INDUSTRY COMPONENTS

FIGURE 4: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY PRODUCT TYPE, 2021 & 2028 (IN %)

FIGURE 5: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY HYDROLASE, 2022-2028 (IN $ MILLION)

FIGURE 6: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY HYDROLASE ENZYME, 2021 & 2028 (IN %)

FIGURE 7: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY HYALURONIDASE, 2022-2028 (IN $ MILLION)

FIGURE 8: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY LYSOZYMES, 2022-2028 (IN $ MILLION)

FIGURE 9: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY OTHER HYDROLASES ENZYMES, 2022-2028 (IN $ MILLION)

FIGURE 10: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYME, 2022-2028 (IN $ MILLION)

FIGURE 11: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYME, 2021 & 2028 (IN %)

FIGURE 12: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY STREPTOKINASE, 2022-2028 (IN $ MILLION)

FIGURE 13: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY UROKINASE, 2022-2028 (IN $ MILLION)

FIGURE 14: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY OTHER THROMBOLYTIC ENZYMES, 2022-2028 (IN $ MILLION)

FIGURE 15: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, 2022-2028 (IN $ MILLION)

FIGURE 16: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, 2021 & 2028 (IN %)

FIGURE 17: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY LACTASE, 2022-2028 (IN $ MILLION)

FIGURE 18: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY L-ASPARAGINASE, 2022-2028 (IN $ MILLION)

FIGURE 19: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY OTHER DIGESTIVE ENZYMES, 2022-2028 (IN $ MILLION)

FIGURE 20: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY ENDONUCLEASE, 2022-2028 (IN $ MILLION)

FIGURE 21: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY ENDNUCLEASE ENZYME, 2021 & 2028 (IN %)

FIGURE 22: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY BENZONASE, 2022-2028 (IN $ MILLION)

FIGURE 23: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY OTHER ENDONUCLEASES, 2022-2028 (IN $ MILLION)

FIGURE 24: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY APPLICATION, 2021 & 2028 (IN %)

FIGURE 25: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY DISEASE TREATMENT, 2022-2028 (IN $ MILLION)

FIGURE 26: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY DIAGNOSTIC TOOLS, 2022-2028 (IN $ MILLION)

FIGURE 27: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY BIOMEDICAL RESEARCH, 2022-2028 (IN $ MILLION)

FIGURE 28: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY OTHER APPLICATIONS, 2022-2028 (IN $ MILLION)

FIGURE 29: ASIA-PACIFIC MEDICAL ENZYMES MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)

FIGURE 30: CHINA MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)

FIGURE 31: JAPAN MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)

FIGURE 32: INDIA MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)

FIGURE 33: SOUTH KOREA MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)

FIGURE 34: ASEAN COUNTRIES MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)

FIGURE 35: AUSTRALIA & NEW ZEALAND MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)

FIGURE 36: REST OF ASIA-PACIFIC MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)

 

The rising chronic disease incidence and enhanced healthcare spending support market growth.

 

MARKET OUTLOOK

A report by Triton Market Research depicts that the medical enzymes market in the Asia-Pacific would develop with a CAGR of 7.67% over the forecasting duration between 2022 and 2028. Japan, ASEAN countries, Australia & New Zealand, India, South Korea, China, and Rest of Asia-Pacific are studied in the market in this region.

The National Pharmaceutical Pricing Policy in India has made access to essential medications easier and affordable. The efficiency of pharmaceutical firms in the nation is boosted by low manufacturing costs and a greater focus on research & development, which is anticipated to support the studied market’s expansion. As per the IBEF, the country’s medication & pharmaceutical exports totaled $5.78 billion between April 2021 and June 2021.

Additionally, in June 2021, the finance minister announced a further INR 197,000 crore expenditure that will be allocated for the Pharmaceutical PLI Scheme for drug intermediaries, API, and other materials. The high economic growth, accompanied by greater health insurance penetration and rising spending on healthcare & medicine, are some of the prime factors influencing the rise of the medical enzymes market in the nation.

The healthcare system in Japan is regarded as one of the best in the world, providing affordable care and superior quality assurance. The nation dedicates almost 10% of its GDP to the advancement of healthcare. Also, the country has a large geriatric population. The number of people who suffer from chronic ailments, including diabetes, cancer, and hypertension, also grows as the country’s elderly population rises. Other issues, including smoking, drinking alcohol, and obesity, are also some health conditions that can be treated using enzymes. This is anticipated to fuel the expansion of the medical enzymes market in Japan.

 

Get more insights into the Asia-Pacific Medical Enzymes Market:

 

https://www.tritonmarketresearch.com/reports/asia-pacific-medical-enzymes-market

 

COMPETITIVE OUTLOOK

The prominent companies in the medical enzymes market are Novozymes, Sekisui, Sanofi SA, Thermofisher Scientific Inc, Novus, Roche Holding AG, BBI Solutions, and Amano Enzyme.

 

SEGMENTATION

1.     BASF SE

2.     DUPONT

3.     ROCHE HOLDING AG

4.     NOVOZYMES

5.     DSM

6.     SANOFI SA

7.     CODEXIS

8.     ADVANCED ENZYMES

9.     AMANO ENZYME

10. BBI SOLUTIONS

11. THERMOFISHER SCIENTIFIC INC

12. CPC BIOTECH

13. NOVUS

14. BRAIN BIOTECH AG

15. SEKISUI